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Abstract
Engineered nanomaterials significantly entered commerce at the beginning of the 21st century. 
Concerns about serious potential health effects of nanomaterials were widespread. Now, 
approximately 15 years later, it is worthwhile to take stock of research and efforts to protect 
nanomaterial workers from potential risks of adverse health effects. This article provides and 
examines timelines for major functional areas (toxicology, metrology, exposure assessment, 
engineering controls and personal protective equipment, risk assessment, risk management, 
medical surveillance, and epidemiology) to identify significant contributions to worker safety and 
health. The occupational safety and health field has responded effectively to identify gaps in 
knowledge and practice, but further research is warranted and is described. There is now a greater, 
if imperfect, understanding of the mechanisms underlying nanoparticle toxicology, hazards to 
workers, and appropriate controls for nanomaterials, but unified analytical standards and exposure 
characterization methods are still lacking. The development of control-banding and similar 
strategies has compensated for incomplete data on exposure and risk, but it is unknown how 
widely such approaches are being adopted. Although the importance of epidemiologic studies and 
medical surveillance is recognized, implementation has been slowed by logistical issues. 
Responsible development of nanotechnology requires protection of workers at all stages of the 
technological life cycle. In each of the functional areas assessed, progress has been made, but 
more is required.
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Introduction
The commercial exploitation of nanotechnology has attracted marked public interest since 
around the year 2000. Workers, including researchers and their students, were the first 
people exposed to the products of this new technology. If nanotechnology was to be 
responsibly developed, workers had to be protected (Schulte and Salamanca-Buentello 
2006). The concern that engineered nanomaterials (ENMs) could be hazardous stemmed 
from awareness of the respiratory and cardiovascular effects of ultrafine air pollutants; 
industrial experience with health effects from welding fumes, and diesel particles, including 
metal fume fever; acute pulmonary inflammation from fumed silica; and various animal 
studies showing translocation of gold nanoparticles from nasal mucosa to the brain (De 
Lorenzo 1970) and respiratory effects due to ultrafine zinc (Amdur et al. 1988). Ultrafine 
particles were found to have greater pulmonary toxicity than larger respirable (fine) particles 
when measured by the mass dose; particle volume and particle surface area were found to be 
more predictive dose metrics (Morrow 1988; Oberdörster and Yu 1990; Duffin et al. 2002). 
Scientific literature on occupational exposures to and health effects from existing aerosol 
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particulates and fibers provided a basis for evaluating the potential hazards of new nanoscale 
aerosols and highlighted gaps in the current body of knowledge (Maynard and Kuempel 
2005).
Caution was initially sounded in 2000, when the United States National Science Foundation 
stated, “As currently envisioned, nanomaterials are likely to possess at least three properties 
that will generate novel safety and governance challenges: invisibility, micro-locomotion, 
and self-replication” (Roco and Bainbridge 2001). In 2004, the insurance company Swiss Re 
was more explicit, stating: “Presumably, nanoparticles must be handled with the same care 
given to bio-organisms or radioactive substances” (Hett 2004). In that same year, The Royal 
Society and The Royal Academy of Engineering warned, “There are uncertainties about the 
risk of nanoparticulates currently in production that need to be addressed immediately to 
safeguard workers and consumers and support regulatory decisions. … The evidence that 
has been reviewed suggests that manufactured nanoparticles and nanotubes are likely to be 
more toxic per unit mass than particles of the same chemical at larger size and will, 
therefore, present a greater hazard.… Free particles in the nanometer size range do raise 
health, environmental, and safety concerns, and their toxicology cannot be inferred from that 
of particles of the same chemical at larger size” (The Royal Society and The Royal 
Academy of Engineering 2004).
In 2004, when scientists from various countries met in Buxton, UK, for the first in a special 
series of nanotechnology occupational and environmental health (NanOEH) conferences of 
the occupational and environmental communities (Fig. 1), there were already over 200 
claimed products identified as “nano-enabled” in commerce, indicating that workers were 
handling nanomaterials (Woodrow Wilson Center 2013). Moreover, the global market for 
nanomaterials was predicted to grow to an estimated $4.4 trillion by 2018 (Lux Research 
Inc. 2014). This meant that scientists and government officials had to answer not only 
whether the material was harmful, but also whether there were exposure and risk, and 
simultaneously, they had to devise strategies for handling nanomaterials safely. These 
NanOEH conferences represented periodic ad-hoc gatherings of the occupational safety and 
health community to address potential hazards of a new technology. They served to 
stimulate networking and discussion of emerging findings and needs in nanosafety research.
After almost two decades of commercial activity, it is worth assessing whether progress has 
been made on the critical issues of occupational safety and health in nanotechnology. In this 
article, we examine the history of the occupational safety and health efforts regarding ENMs 
from 2000 to 2015. To better explore progress in this field, eight important topical areas are 
distinguished: toxicology, metrology, exposure assessment, engineering controls and 
protective equipment, risk assessment, risk management, medical surveillance, and 
epidemiology. For each topical area, major milestones have been identified, including 
significant technical or research achievements as well as policy recommendation or adoption 
by national agencies, international government organizations, or professional non-
governmental organizations. The selection of these milestones is based on the experience 
and judgment of the authors and includes consideration of the import assigned to actions and 
works by professional communities, as well as the volume of citations (as indicated by 
Google Scholar, Assessed August–September 2015) for academic literature. The selected 
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milestones are then synthesized into timelines to allow a historical portrayal of critical 
findings and actions that have advanced knowledge in that area. Although this is a 
qualitative approach, this method provides a better context than would be available by a 
strictly quantitative review of the academic literature. Moreover, it allows one to more 
readily see not only how the field came to reach its current state, but also the current tasks 
and challenges in each area that remain to be addressed.
Toxicology
The initial question from workers, employers, and other decision-makers was whether 
ENMs are harmful and, if so, what mechanisms and properties explained their toxicity. 
Many of the toxicological methods and models used to investigate nanomaterial health risks 
have their origins in studies of the toxicology of particles and fibers (Kreyling et al. 2002a; 
Oberdörster et al. 2005b). Studies investigating the unique or enhanced properties of 
nanomaterials published prior to 2000, have led to the current field of nanotoxicology 
(Donaldson et al. 1998; Oberdörster et al. 1992, 1994). A major focus of these studies has 
been effects on the respiratory tract, because of the history of occupational respiratory 
diseases associated with aerosol exposures. Nanoparticles are respirable, which enables them 
to reach the gas-exchange (alveolar) region of the respiratory tract (Oberdörster et al. 
2005a). Nanoparticles have also been observed to reach the interstitium and the blood, which 
may represent a path for the translocation of inhaled nanoparticles from the lung to 
secondary organs (Donaldson et al. 2004; Kreyling et al. 2010; Mercer et al. 2010, 2013). 
Carbon nanotubes (CNTs) also appear to rapidly promote interstitial fibrosis, and specific 
multi-walled CNTs (MWCNTs) have been shown to promote lung cancer (Sargent et al. 
2014). Beyond this, inhalation of nanoparticles has been linked to cardiovascular effects (Li 
et al. 2007; Nurkiewicz et al. 2008). The toxicological behavior of ENMs and natural or 
incidental ultrafine particulate matter has been observed to be quite similar (Gwinn and 
Vallyathan 2006). It is thought that inhalation is the main route of exposure, as insoluble 
nanoparticles do not generally traverse the intact skin (Rouse et al. 2007). However, there 
does not appear to have been a comprehensive study of cutaneous exposure, which leaves 
unanswered certain questions about reliability of cross-species models for nanoparticles, 
effects of nanoparticle functionalization on penetration, and the degree to which different 
forms of skin damage might affect penetration.
Nanoparticle toxicity is increasingly thought of as a confluence of multiple contributory 
mechanisms stemming from the physicochemical properties of a given nanomaterial. Much-
like inhalation of fine and ultrafine particles, nanoparticle size does affect (but does not fully 
govern) the toxicity (Maynard and Kuempel 2005; Oberdörster et al. 2005a). For instance, 
insoluble nanoparticles have been shown to have inhalation toxicity proportional to the total 
surface area (and thus inversely proportional to individual particle size) (Oberdörster et al. 
1992; Driscoll 1996; Tran et al. 1999). Additional important factors that influence particle 
toxicity include surface reactivity, solubility, and shape (Duffin et al. 2002; Maynard and 
Kuempel 2005). Some indicated mechanisms are: (1) release of ions into solution; (2) 
generation of oxidative stress by facilitating the generation of electron–hole pairs to create 
reactive oxygen species in the microenvironment; (3) semiconductive properties causing 
ejection of excited electrons to create superoxides, directly catalyzing electron transport in 
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redox regulators; and (4) fiber-induced biological responses. Each of these mechanisms may, 
in turn, promote an immune response. These mechanisms appear to be associated with the 
particle’s physicochemical properties (the size of the particle, shape, porosity, chemical 
composition, and any functionalization), but the cellular response to these toxic insults may 
be the primary dictator of outcomes Donaldson et al. (1998, 2004, Nel et al. 2006, 2009; 
Palomaki et al. 2011; Schins and Knaapen 2007). By 2010, the knowledge of toxicology had 
grown considerably, and reviews began to focus on the integration of that knowledge with 
other occupational health-related fields and the gaps that existed (Seaton 2006; Bergamaschi 
2009; Savolainen et al. 2010a).
Figure 2 shows the timeline for toxicology progress. Critical points in the timeline were 
initiation of nanomaterial testing by the Organization for Economic Co-operation and 
Development (OECD) in 2006, findings of possible carcinogenicity from animal studies 
conducted in 2008–2013, and critique of the toxicological research in 2014, which called for 
a better particle characterization (Krug 2014). A commentary by Yu et al. in the following 
years recognized a disconnection: despite tremendous advancement in the field, there were 
only questionable data relating the experimental findings to human hazards (Yu et al. 2015). 
Bridging this gap is going to become increasingly important, not only for occupational 
health, but also for medical applications of ENMs (Cattaneo et al. 2010). At the current 
stage, there is a large body of literature on the toxicology of ENMs (both quantitative and 
mechanistic). However, gaps remain both in the ability to extrapolate toxicity of selected 
ENMs to related classes of ENMs and in translating our knowledge from the petri dish, 
microarrays, or laboratory animal to the human worker.
Metrology
By 2000, it was clear that metrology was going to be critical for understanding NanOEH. 
ENMs were quite varied, at the limits of many instruments’ ability to measure, and it was 
still unclear which properties were essential for understanding toxicity and exposure and for 
devising control schemes. The question was: What nanomaterial physiochemical properties 
should be measured, and how? This question directly impacted both laboratory toxicology 
studies, requiring a thorough characterization of study materials to understand exposure–
response relationships, and workplace exposure assessments, which require differentiation of 
the ENMs of interest from other nanoscale particles in workplace atmospheres. From 
toxicology studies, it was becoming clear that multiple ENM physicochemical properties 
could affect the toxicological response. As such, initial approaches to characterization of 
ENMs sought to measure as many properties as possible to enable understanding of potential 
exposure– response relationships (Bouwmeester et al. 2011). Such strategies are not 
practical, economically viable, or technically feasible and, therefore, necessitate more 
targeted characterization strategies. With regard to assessments of ENMs in workplace 
atmospheres, investigators were initially faced with the challenge that many sampling and 
analytical methods lacked specificity for the ENMs of interest, which made it difficult to 
differentiate them from airborne incidental “background” nanoparticles (Methner et al. 
2007).
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Though the best metric(s) for understanding ENM health effects are still unknown and likely 
vary with material and health endpoint (Jiang et al. 2008), increasingly, there have been 
efforts to better define ENM characterization strategies. For example, many investigators 
have attempted to define a minimum set of nanomaterial properties (surface area, elemental 
composition, particle size, particle-size distribution, zeta potential, and crystallinity) to 
thoroughly characterize an ENM for toxicology studies (Stefaniak et al. 2013). It is now 
recognized that to overcome weaknesses in sampling and analytical methods, because of 
non-specificity, field exposure studies need to be carefully designed to compensate for 
background nanoparticle exposures; in addition, findings potentially must be reevaluated 
with more specific, but costlier and time-consuming analytical methods, such as electron 
microscopy (Methner et al. 2007). This is also necessary, because many real-time 
instruments [such as scanning mobility particle (SMP) analyzers and condensation particle 
counters (CPCs)] used in field studies are limited to assaying a single parameter (such as 
particle-size distribution) and cannot develop the detailed characterization data set required 
for more rigorous exposure assessment and risk assessment.
Figure 3 is the timeline for progress in nanomaterial metrology. A significant progress has 
been made in developing reference materials to support particle identification, in refining 
toxicology characterization strategies, and in clarifying field exposure measurements. Going 
forward, the ability to develop a complete picture of toxicity and exposure results from 
numerous tests by different laboratories—and to reach a broader understanding of the 
exposures associated with specific materials and processes—will require a set of common 
standards (Linsinger et al. 2011; Stefaniak et al. 2013). These standards may be in the form 
of existing and new reference materials, study protocols, and agreed-upon guidance. The 
National Institute of Standards and Technology (NIST) began introducing nanoparticle 
reference materials in 2008, with the release of three sizes of gold nanoparticles (NIST and 
National Cancer Institute [NCI] 2008). Since then, at least 18 such well-characterized 
materials have entered common usage throughout the US and Europe, including carbon 
nanotubes (CNTs), metals and metal oxides, and cellulose nanocrystals (Germany Federal 
Institute for Materials Research and Testing [BAM] 2015). In addition, the European 
Union’s Joint Research Centre’s Nanohub has begun to amass a repository of well-
characterized nanomaterials specifically to “promote better reproducibility and reliability of 
nanomaterials safety testing” (Joint Research Centre 2014). Reference materials may be 
essential for overcoming the lack of standardized measuring practices, allowing 
interlaboratory comparison and instrument calibration. The NanOEH community needs to 
decide whether reference materials are really necessary or if “study,” “benchmark,” or 
“representative test” materials are sufficient for an intended purpose (Roebben et al. 2013). 
Test methods are becoming available from ISO and ASTM International, and guidance 
documents are freely available from the U.S. National Cancer Institute (http://
ncl.cancer.gov/assay_cascade.asp) and consortiums, such as the Center for Environmental 
Implications of NanoTechnology (http://www.ceint.duke.edu/allprotocols). Finally, 
continued development of standards for terminology will be critical for ensuring sound 
metrology that best supports toxicological characterization and workplace exposure 
measurements.
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Initially, there was little understanding of ENM exposures, although the ability to protect 
workers and make decisions requires well-developed methods of exposure assessment. Once 
metrology enabled the study of ENM exposures, characterization commenced immediately. 
Initial forays into assessing exposures to ENMs borrowed heavily from the techniques of 
sampling for particulate matter and asbestos (Kuhlbusch et al. 2004; NIOSH 2009a). 
Maynard et al., who examined a single-walled carbon nanotube (SWCNT)–generating 
operation using an SMP analyzer for particle counting and sizing and filter capture, 
demonstrated workplace air concentrations up to 53 µg/m3 (Maynard et al. 2004). In 2007, 
Methner et al. studied a carbon nanofiber (CNF) facility using a real-time CPC as well as 
filter capture, followed by offline analysis with transmission electron microscopy, and 
discovered that the largest amount of particle aerosolization occurred during saw use 
(Methner et al. 2007). These studies demonstrated that ENM aerosols were measurable and 
often linked to specific tasks. However, the studies demonstrated a weakness in the ability to 
measure exposures in a worker’s personal breathing zones, as well as the need for a more 
consistent sampling protocol that could differentiate background concentrations of 
incidental, non-engineered nanoparticles (such as diesel exhaust matter). Several studies by 
Brenner et al. demonstrated an approach to systematic exposure assessment for ENMs in 
semiconductor-related tasks (Brenner et al. 2015; Shepard and Brenner 2014a, b). Similar 
methods were demonstrated by Lee et al. in an investigation of a plant creating silver ENMs 
(Lee et al. 2012).
In addition, the advances in toxicology brought into question whether ‘mass per unit volume 
of air’ was a sufficient exposure metric. Maynard and Aitken outlined the numerous 
physicochemical parameters that seemed to be related to toxicology and developed a 
categorization scheme that would indicate the most critical parameter to analyze for a given 
category of material (Maynard and Aitken 2007). It was also recognized that no single 
measuring tool available could attain all the desired parameters and that the field would 
benefit from an economical, portable tool for simultaneous examination of particle mass, 
and number and development of area-to-volume ratios (Maynard and Aitken 2007). To date, 
such a device remains elusive. Brouwer et al. also examined critical deficiencies in the field, 
noting that in spite of the data governing nanoparticle behavior, the lack of sufficient field 
data or a unified sampling approach made it difficult to draw meaningful conclusions from 
the current exposure data sets (Brouwer et al. 2009).
The need for a more comprehensive and unified approach was addressed by several groups. 
In the US, the National Institute for Occupational Safety and Health (NIOSH) developed and 
demonstrated the Nanoparticle Emission Assessment Technique (NEAT), which specifically 
highlighted the need for surveying discrete tasks in a workplace as well as the need for 
analysis with multiple tools (including particle counters and filter samples analyzed by 
electron microscopy) of reference samples from the material of interest (Methner et al. 
2009). The EU-sponsored NANOSH (Finnish Institute of Occupational Health 2010) 
emphasized the need for harmonized decision logic, measurement strategy, and data 
reporting, as well as the use of multi-instrumental analysis (Brouwer et al. 2009). In 2012, 
Brouwer et al. reported that the First International Scientific Workshop on Harmonization of 
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Strategies to Measure and Analyze Exposure to (Manufactured) Nano-objects in Workplace 
Air had recommended a multi-metric approach combined with specifics in sampling 
approaches and contextual data gathering (Brouwer et al. 2012). OECD followed the 
guidance of Brouwer et al. by recommending a tiered approach consisting of an initial 
survey of work tasks and identification of potential sources of exposure, followed by rapid 
assessment of a few key parameters (such as concentration measurements) and then, detailed 
assessment of all potentially related parameters (surface chemistry testing, imaging, etc.) 
(Organisation for Economic Co-operation and Development 2015).
An example of these practices can be observed in the 2012 report by Dahm et al., in which 
careful decision-making and multiple techniques enabled the research group to demonstrate 
statistically significant correlations in exposure between elemental carbon levels and 
CNT/CNF exposures (Dahm et al. 2012). As a direct consequence of such quality studies, 
the amount of available exposure data is increasing rapidly, and therefore, the field is 
becoming more sophisticated. In 2015, two studies were published that compared numerous 
sites and sampling events to derive high-confidence conclusions (Bekker et al. 2015; Dahm 
et al. 2015); Bekker et al. were able to define the highest-exposure task in their study. Such a 
comprehensive sampling strategy, consistently applied and using a multifaceted 
methodology, represents the future of occupational nanoparticle exposure assessment. 
Advances in the field of exposure assessment for ENMs are presented as a timeline in Fig. 4. 
Despite these advances, the body of published exposure data focuses extensively on CNTs 
and TiO2 and, to a lesser extent, on a few other commercial nanomaterials, such as noble 
metals (silver), metals and metallic oxides (iron, zinc, aluminum), carbon black, and other 
carbonaceous materials, such as fullerenes (Bekker et al. 2015; Brouwer 2010; Kuhlbusch et 
al. 2011). There remains a need to expand investigations of exposures to other types of 
ENMs, such as multilayered or functionalized nanoparticles.
Engineering controls and personal protective equipment
Once exposures could be assessed, it was critical to evaluate which control measures could 
mitigate exposure. Occupational safety and health practitioners drew upon the long and 
successful history of controlling fine dusts and dry powder formulations in pharmaceutical, 
nuclear, coating, pigmentation, and cosmetic industries to identify effective exposure 
containment and control strategies for industries involved in generating or using ENMs. This 
was supported by the accumulating body of evidence, indicating that nanoparticles followed 
laws of aerosol physics in their airborne behavior and, therefore, were susceptible to 
established exposure control technologies. Further investigations concluded that worker 
exposures were directly linked to specific material handling practices and processing tasks 
(NIOSH 2009a). Many of these processes were directly analogous to classic manufacturing 
processes, and as with many historical workplace contaminants, the potential for inhalation 
exposure became a focus. However, because of the greater respiratory deposition of 
nanoparticles versus microparticles, more emphasis was placed on exposure control 
strategies that could capture the smaller aerosols. A secondary concern was dermal 
exposure, because of the ability of some types of nanoparticles to enter through damaged 
skin. Initial exposure control recommendations included the use of local exhaust ventilation 
(LEV), equipped with high-efficiency particulate air (HEPA) filters, if needed; use of damp-
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cleaning methods or HEPA-equipped vacuums for cleaning; and use of impermeable 
materials for gloves (NIOSH 2009a).
These initial recommendations were validated by recent studies. A study by Methner in 2008 
found that in the process of generating 15- to 50-nm-diameter metal-alloy spheres, a single 
process (cleaning a reactor) generated the most airborne nanoparticles. The study also 
showed that installation of LEV with a HEPA filter (since discharge was impractical in the 
self-contained system) could result in a mean airborne reduction of 88 % mass-concentration 
(µg/m3) (Methner 2008). Another investigation, by Rengasamy et al. (2008), found that N95 
and P100 filtering face-piece respirators typically removed in excess of 95 % of 
nanoparticles, with the effectiveness increasing as particle diameter decreased below 30 nm 
(Rengasamy et al. 2008). Safe Work Australia discussed the methods by which nanoparticle 
trapping occurs and further recommended exploration of the use of electrostatic precipitators 
and, for some processes, full enclosure as well as eye and facial protection (Safe Work 
Australia 2009).
The uncertainty of exposure risk for a given ENM can complicate determination of the 
appropriate controls. A control-banding approach introduced by Paik et al. (2008) ranks 
materials on a 1–4 scale, based on both the particle toxicity and the probability of exposure, 
with conservatively high assumptions for unknown parameters. Each control band is then 
matched with a specific set of recommended controls (Paik et al. 2008). This technique is 
part of a growing toolbox of accepted methods for controlling ENMs, despite uncertainties 
about specific nanomaterials (NIOSH 2013a).
A growing body of studies is available from NIOSH and the United Kingdom Health and 
Safety Executive (HSE) to guide decisions on controls and selection of personal protective 
equipment (PPE) both for general nanomaterial use and specific processes of interest. These 
recommendations are strongly rooted in the identification of exposure risks that are both 
task-derived and toxicology-dependent, and they help bring to bear scientifically 
demonstrated methods of mitigation through engineering controls, followed by PPE. In 
addition, efforts are ongoing to develop a method for sharing best practices in occupational 
health and to develop the technologies necessary to enable better assessment of the efficacy 
of engineering controls (Sirviö and Savolainen 2011). This cooperative development will 
complement other global efforts to develop standards to assess and mitigate ENM hazards. 
Advances in the field of engineering controls and PPE for ENMs are presented as a timeline 
in Fig. 5.
Risk assessment
One of the driving questions in the early 2000s was whether workers exposed to ENMs were 
at risk of adverse health effects and to what extent those effects depend on the nanoscale 
properties. The limited data and uncertainty on the toxicity and environmental behavior of 
ENMs made risk assessment difficult initially. However, standard risk assessment methods 
and dosimetry models that account for differences in the lung doses in animals and humans 
have been used in quantitative risk assessments of ultrafine or fine particles (Kuempel et al. 
2006). These methods were used to estimate the particle-size-specific pulmonary disease 
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risk of titanium dioxide (TiO2) on the basis of retained particle surface area lung burden 
(Dankovic et al. 2007). Particle volume lung retention was the dose metric used by Pauluhn 
to derive an occupational exposure limit (OEL) for MWCNT, using the lung particle 
overload hypothesis (Morrow 1988; Pauluhn 2010). Default uncertainty factor approaches 
have also been applied to derive OELs for several types of nanoparticles (Aschberger and 
Christensen 2011). NIOSH has published recommended exposure limits for ultrafine and 
fine TiO2 and for carbon nanotubes and nanofibers based on quantitative risk assessments 
(NIOSH 2011, 2013b). As the number of nanotoxicology studies continues to increase, the 
challenge is how to effectively translate these research findings to occupational safety and 
health practice (Schulte et al. 2010).
To address the paucity of data for most nanomaterials, the OECD has recommended 
categorizing materials into similar categories based on physicochemical properties to 
extrapolate reasonable estimates of the bioactivity of a nanomaterial (Organisation for 
Economic Co-operation and Development 2007). The British Standards Institute (BSI) and, 
soon after, the Institute for Occupational Safety and Health of the German Social Accident 
Insurance (IFA) proposed broad categories of nanomaterials with provisional exposure 
limits. They also examined the parameters that indicate the risk a material may pose, with a 
particular emphasis on respiratory risks and mention of others, including those that might be 
sensitizers or explosion hazards (BSI 2007; Netherlands National Institute for Public Health 
and the Environment 2014). Hazard-based grouping and risk-based grouping of 
nanomaterials by comparative potency analyses of data-rich benchmark materials with data-
poor nanomaterials have been proposed to supplement evidence from nanotoxicology 
research (Kuempel et al. 2012a). A similar concept is the “biaxial approach,” which was 
developed to incorporate detailed examinations of representative materials with simpler 
assays of new nanomaterials (Nakanishi et al. 2015). “Read across” approaches are also 
being used to interpolate unknown material bioactivity from other materials with similar 
physicochemical, exposure, and hazard properties; and such approaches, while not 
universally accepted, offer a useful way to interpret the often incomplete data on ENMs 
(Organisation for Economic Co-operation and Development 2012; Sellers et al. 2015; Stone 
et al. 2014). Advances in risk assessment for ENMs are presented as a timeline in Fig. 6.
Risk management
With the increasing awareness of potential adverse health effects from ENMs, employers 
wanted to know how to manage any related risks. Protecting against occupational illness by 
identifying, managing, and preventing risks from ENM is the ultimate goal in occupational 
safety and health. Initially, although there was some general risk management experience 
with fine and ultrafine particles, HSE and NIOSH examined nanomaterial toxicities and 
exposures and concluded that the available data were insufficient to be certain of proper 
exposure mitigation methods and engineering controls, highlighting risk management as an 
important area of future study (NIOSH 2011; UK Health and Safety Executive (HSE) 2004). 
Independent health researchers concurred, and Maynard observed that because of the rapid 
rate of ENM development, it was critical for an analytical framework to be developed 
quickly and to incorporate exposure mitigation models that had a long lifespan (Maynard et 
al. 2006).
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With cognizance of the knowledge base needed for risk management, organizations, such as 
the ISO Technical Committee 229 Working Group moved to address issues of nanomaterial 
nomenclature, metrology, and environmental health and safety by proposing a set of 
guidelines and the use of control banding (International Organization for Standardization 
(ISO) 2012). Initial risk management recommendations were maximally protective, often 
incorporating full containment of potential ENM exposures and emphasizing the importance 
of medical surveillance (NIOSH 2009a). The introduction of models, such as the Nano Risk 
Framework, promoted the use of a systematic approach used by the chemical industry to 
manage the introduction of new materials (Environmental Defense—DuPont Nano 
Partnership 2007). Such frameworks compensate for a lack of knowledge in specific 
toxicities and exposure, which, despite the advent of well-validated methods of exposure 
assessment and control using NEAT, remains a persistent problem (Gulumian et al. 2012; 
Methner et al. 2010a, b). Application of these frameworks has accelerated the development 
and proposal of a standardized control-banding approach to manage ENMs (International 
Organization for Standardization (ISO) 2013).
At this time, guidelines for managing occupational exposure to ENM have been issued, with 
special guidance for specific nanomaterials (CNTs and high-aspect-ratio nanomaterials) 
(Institute for Occupational Safety and Health of the German Social Accident Insurance 
(IFA) 2009; UK Health and Safety Executive [HSE] 2013). In addition, information on risk 
management is being published that targets the employer, employee, and health and safety 
professionals, enabling better training and helping facilitate better risk management 
programs (European Commission on Employment 2014a, b; Kulinowski and Lippy 2011). 
Advances in risk management for ENMs are presented as a timeline in Fig. 7. These efforts 
are bearing fruit in the development by universities and research institutions of sophisticated 
risk management plans with nuanced decision-making logics rooted in established concepts, 
such as control banding (Grieger et al. 2015; Groso and Meyer 2013; Groso et al. 2010).
Medical surveillance
A question that arose early in the development of ENMs was whether workers’ health 
should be monitored. Medical surveillance (tracking the health of workers over time) is a 
critical tool for evaluating the health effects on workers potentially exposed to occupational 
hazards. In the case of ENMs, the limited data set available on hazards, exposure 
concentrations, and risk management effectiveness increased the perceived need for a 
general medical monitoring program for nanomaterial workers. However, that same lack of 
information in other areas also extends to understanding pathologies associated with ENM 
exposure. To date, no specific human illnesses have been definitely associated with ENM 
exposure, although some biomarkers of effect that may be associated with adverse effects 
have been identified (see section on epidemiology). Consequently, specific medical 
screenings (clinical tests) have not yet been recommended for most ENMs, but general 
medical surveillance is a prudent precautionary measure for workers exposed to ENMs 
(Nasterlack et al. 2008; NIOSH 2009b). To generate a more comprehensive data set for 
future surveillance efforts, the creation of a registry with information on workers potentially 
exposed to ENMs is an option being explored in various countries (Boutou-Kempf et al. 
2011; Health Council of the Netherlands 2012).
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Specific medical screening of workers exposed to selected ENMs may be warranted if an 
ENM is composed of a compound that has known toxicity and is already subject to medical 
screening (Trout 2011). Similarly, specific materials whose potential pathologies are well 
understood might be subject to more specific medical screening. Examples of such 
nanomaterials are CNTs and CNFs, because of the human pulmonary effects anticipated on 
the basis of extensive toxicological research (NIOSH 2013b).
It is also essential to carefully consider the structure of any medical surveillance, to ensure 
that the information gathered does not become the primary object rather than the 
maintenance of worker health (Nasterlack 2011; Schulte and Salamanca-Buentello 2006). 
Although there is a strong ethical impetus to use all available methods to characterize ENM 
health outcomes, caution must also be used to avoid errors in data analysis when well-
defined health endpoints from an exposure are unknown (Fischman et al. 2011). However, 
when used properly, medical surveillance is a powerful tool for risk management and can 
also serve as a mechanism to assess the health status of a group of workers exposed to a 
specific ENM. Establishment of such a program can provide critical knowledge to workers 
and involve them in the process of establishing a safe work environment (Schulte and 
Salamanca-Buentello 2006). Advances in medical surveillance for ENM workers are 
presented as a timeline in Fig. 8.
Epidemiology
Whether worker populations exposed to ENMs were at risk of adverse health effects was 
another early question that has awaited an answer. Because of the relatively short period of 
occupational exposure to ENMs for most workers and the time required for development of 
long-latency outcomes, such as pulmonary fibrosis and cancer, insufficient time has passed 
to measure many occupational diseases, and few epidemiologic studies have been 
conducted. Challenges in developing epidemiological studies are significant. Most 
prominent among the logistical challenges are the difficulty of identifying a subject 
population (which is linked to the small number of workers exposed to a specific ENM 
employed in many diverse industries) and the requirement of consistent tasks with relevant 
materials and exposures for a long period of time to elucidate chronic outcomes (Schulte et 
al. 2009). These challenges are due to the fact that there is not a single “nanotechnology 
industry,” but rather a collection of different industries that are enabled by nanotechnology, 
resulting in difficulties finding large groups of workers exposed to the same ENM.
Factors that could improve the development of epidemiological studies include: consistency 
in documenting ENM characteristics, a lack of confounding information on other toxicants 
in the workplace, and a proper range of exposure concentrations (that is, not entirely 
attenuated or rendered inconsistent by controls or PPE) (Laney et al. 2011; Schulte et al. 
2009). Prior to the study published by Liou et al. (2012), few studies had focused on 
nanomaterial workers, although studies had been conducted on naturally occurring or 
incidental exposures to nanoparticles, largely in the form of air pollution (Liou et al. 2012).
A more generalized plan was introduced by Riediker et al. (2012), which broke the general 
need for epidemiologic studies into subquestions divided into categories more closely linked 
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to materials and exposure assessment, determination of endpoints and markers, and elements 
of risk management, study design, and data analysis. This context recognized the need for 
advances in each field to determine the ideal analytical techniques for exposure assessment, 
determination of exposure biomarkers, and data handling methods as well as cross-talk 
between each to yield a more useful final result (Riediker et al. 2012).
In the last several years, a significant progress has been made in many of the critical areas 
outlined by Riediker et al. (2012). France has begun to implement a broad, compulsory 
surveillance plan for workers exposed to CNTs, which could potentially be broadened to 
other ENMs, forming a large database for epidemiologic data mining (Canu et al. 2013). 
Iavicoli released a comprehensive survey of biomarkers useful for potential ENM-related 
epidemiology categorized into markers of exposure for specific materials, common 
outcomes, and genotoxicity (Iavicoli et al. 2014). A case study reported by Journeay and 
Goldman demonstrated that certain ENMs might also have the ability to act as sensitizers 
(Journeay and Goldman 2014), suggesting this as a possible health outcome to be monitored 
by future epidemiology studies. In addition, in 2015, Ostro et al. and Peters et al. each 
published an epidemiologic study linking ultrafine exposure to negative cardiovascular 
outcomes in female teachers and type II diabetics (Ostro et al. 2015; Peters et al. 2015).
In a review of early ENM-related epidemiological studies, Liou et al. compared 11 cross-
sectional studies and 8 longitudinal studies, finding that the use of biomarkers was prevalent 
and a small number of nanomaterials had been tested (including but not limited to silver, 
CNTs, and TiO2), and all suffered from limited exposure assessment and sample size (Liou 
et al. 2015).
Nanomaterial usage is increasingly diversified, with many nanomaterials potentially having 
several different uses for multiple key industries. Thus, identification of an appropriate 
sample group for epidemiological studies will remain a challenge for the near term (Schulte 
et al. 2009), and significantly more data and studies are needed in this area. Advances in the 
field of ENM worker epidemiology are presented as a timeline in Fig. 9.
Conclusions
Although a great deal of progress has been made in NanOEH during the past two decades, 
further research and development are still required in each of the eight identified areas. 
There are now many published toxicology reports, which have identified possible 
mechanisms of action. Large numbers of diverse materials and models have been tested, but 
the potential hazards of the vast majority of nanomaterials are unknown. To build on the 
work thus far, it is necessary to synthesize a standard approach that combines knowledge of 
hazards, exposures, and risk assessment, which can then be used to formalize a clear 
decision-making logic model that will allow prioritization of resources to manage ENM-
associated risks (Kuempel et al. 2012b). There is a substantial lack of long-term animal 
studies, which weakens the strength of the toxicological findings. Although sampling and 
analytical instrumentation and methodology have become increasingly sophisticated, 
allowing for better occupational exposure assessments and more laboratory precision, 
metrology, similarly, needs to be evaluated and standardized. Common ENM reference 
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materials and study protocols need to be adopted to enable data to be more easily compared, 
interpreted, and applied.
Although exposure assessment methods with sophisticated approaches and logics have been 
developed, the total volume of data is still small and remains isolated, preventing meta-
analysis. As much of the analysis has been focused on a few classes of nanomaterials, such 
as CNTs, attention should be paid to a broader range of ENMs. Adoption of forward-looking 
risk management approaches, such as control banding, and more standardized analytical 
frameworks to characterize ENMs has been a significant step in coping with uncertainty 
about ENMs. The best occupational risk management frameworks are still broad and would 
benefit from further refinement.
Although the usefulness of medical surveillance for workers exposed to ENMs is accepted 
among health practitioners, a basis for specific medical screening guidance is still lacking. 
Epidemiologic investigation of the nanomaterials workforce is a relatively young field and 
suffers from a deficit of data (such as information on exposures with types of industries/
processes/job tasks). However, a framework for designing, executing, and analyzing studies 
has taken form in the literature. Finally, a critical measure beyond these eight areas is global 
compliance with available risk management guidance. This guidance is important, because 
there are still many uncertainties about potential health effects of ENMs. Few studies have 
examined the level of adherence to such guidelines by academia and industry, and such 
assessments are crucial to understand whether the knowledge gained from toxicological 
research and workplace exposure assessments is being disseminated in a way that is both 
comprehensible and practical for use by employers and in helping to protect the workers.
Responsible development of nanotechnology requires protection of workers at all stages of 
technological development. In each of the functional areas assessed, progress has been made 
but more is required. While our knowledge has grown, there is still a need for a better and 
faster hazard assessment, capabilities to handle of diverse ENMs and matrices, and 
understanding of actual worker exposures, in addition to a more standardized system of 
methods to allow these data to be more effectively gathered and compared by different 
researchers in distant locations. A maturing NanOEH field has two critical and 
interdependent needs: (1) continuing targeted and high-quality research into the areas of 
toxicology, metrology, medical surveillance, and epidemiology, and (2) harmonization of 
methods for conducting assays, assessing exposure, and assessing risk. A good start has 
been made, but more effort is needed.
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